They were younger with higher body mass index (BMI), higher prevalence of hypertension, higher BP on admission, higher albumin levels, lower prevalence of both cognitive impairment and dependence in ADL, and also lower CRP levels than patients not taking RASi. The gene discussed is CRP; the disease is hypertensive disorder.